@ax5.lo: برأيك الحب تسلية ولا حقيقة ؟ 😢 ): #اكسبلور #منشن_للي_تحبه #فديوهات_بدون_حقوق #فديوهات_شاشه_سوداء #viral #fypシ #foryoupage #foryou #رائد_الشعيبي

الحساب للبيع
الحساب للبيع
Open In TikTok:
Region: SA
Monday 28 August 2023 20:26:22 GMT
268708
11256
263
1185

Music

Download

Comments

user9503245620569
بنت الشيخ :
الي يجيب هل أغاني احسه يعرفني........ ليه؟!
2023-11-10 17:47:43
3
user9409863005212
اميرة :
انت تشبه حبيبي 🥺
2023-10-01 19:24:56
3
user9503245620569
بنت الشيخ :
لا والله تسليه البداية تحسه صدق بعدين النهايه تصير تسليه حسبي الله عليهم 💔🥀
2023-11-10 12:20:33
2
mazen_ff.a
شامي :
ما شفته ولا لقيته 😂💔
2023-08-30 19:33:33
10
.5rr07
الحرف الذي لا يتكرر🌷 :
🥺ساكتفي بالسكوت وكتم الدموع وتسالني الدموع عينيك تبدو جميله... 🥺😓
2023-08-31 19:00:33
19
user3265053425317
عاشقه الصمت🤐 :
حقيقة وتسليه لمن لا يعرف قيمته
2023-10-13 21:51:09
4
user4297307625408
user4297307625408 :
وصحاب المنشور وربي مثل القمر طلته وصفحته
2023-11-11 08:57:24
2
ibram604
الغرام٤٦ :
حقيقه بس في ناس ماله بالهوى سبه
2023-10-24 10:19:25
1
maha_2010r
ࢪغـودة|| 𝑹𝒂𝒈𝒉𝒂𝒅🥷🏻. :
حبيتتتت متل قمر يوم هلي 😭🥰
2023-10-12 19:06:09
10
rm0a8
𝑤𝑟𝑦𝑑،♡゙ٌ𝒉 :
الحب الحقيقي اولها الاهتمام والثانيه التضحيه💔💔.
2023-08-29 16:07:22
11
velid538
بًدٍوٌيَ)♕☞ نِعٌيَمًيَ♕ :
لــــوكـــآن لــي ان اكــــون شيئـــآ...لكـــنت نبضــــآ لايفــــآرق قلـــبك ابــــدآ…❤️مجرد ذوق ❤️
2023-08-30 06:50:30
7
vj.3jj
◝﮼˼♯̶سـنأإفي أإلوأإدي 𓍼ོ◟ :
مدري .
2023-08-31 19:38:21
9
suhaibaljaafari2
صهيب الجعفري شـخصـيـﮯآً 🇾🇪🥀 :
الأمر ليس صعباً، ولن يكون صعب، لسبب بسيط أن اللّٰه معك. يساعدك، يساندك، يوفقك.
2023-08-28 20:39:29
4
z37395
لم يتم العثور على الحساب :
علا حسب الاشخاص الذي عنده قلب مستحيل يتسلا
2023-08-28 20:50:56
4
momohj28
👉🥺القران الكريم👈 :
(ياطير ماشفت خلي )😞😴
2023-08-29 20:47:03
5
al_saudi27
الـســعــودي☄️ :
فديت روحه فديته ♕N♕🥺
2024-05-09 23:14:37
2
np.vx
أبو صهيب :
فديت روحة فديتة 🥺
2023-08-28 20:28:42
5
404_mww
الرشيديه 🤍 :
لا والله حقيقه
2023-10-31 17:33:08
4
user23017126359181
ميسان :
يجنننن
2023-08-29 16:26:02
5
saar_330
المترفه :
ربي يسعدك 🌸
2023-08-28 21:16:59
7
shok585
Sh🤍. :
مثل القمر يوم هلي
2023-09-29 14:06:27
5
sry____2003
M :
فعاليه
2023-08-31 14:31:29
5
retallrr56
𓆩ˋ The light is off ˊ𓆪 :
اذا كان صدق حقيقه واذا كان استغلال تسليه 💔
2024-10-05 01:16:17
1
.s.6.m
.S.6.M 不 :
اي تسلية بس لا تقلب المواجع 💔💔
2023-08-29 15:58:38
4
To see more videos from user @ax5.lo, please go to the Tikwm homepage.

Other Videos

⭐️ This ASCO Study by Chong G et al. looked at 7,018 patients with stage 1-3 breast cancer classified as ER low who have received chemotherapy. 73% were PR negative and 65% were HER2 negative.  Out of these patients, 42% did not receive adjuvant endocrine therapy. Omission of endocrine therapy was more common in patients that were PR negative and had Ki67>=20%, higher grade, clinically node negative and patients who received neoadjuvant chemotherapy.  ❓What did they find?  -At an average follow-up of 3 years, 586 people died.  -94.3% of patients were alive at 2 years and 87.6% were alive at 4 years -Omission of endocrine therapy was associated with a worse overall survival regardless of PR status, HER2 status and Ki67 status.  🚨 The impact on survival by omitting endocrine therapy was only seen in those who did not have a pathologic complete response after neoadjuvant chemotherapy. In the patients who didn’t have a pCR, omission of endocrine therapy was associated with a 25% increase in the risk of death.  🚫 Limitations are that this was a retrospective study (meaning they looked back to find the data). We do not know the type of chemo, duration or adherence rates of endocrine therapy and breast cancer recurrence as all that data is not available. This study also did not look at ER 0%/PR positive disease so it’s hard to extrapolate to this population but we should keep this data in mind as we think about endocrine therapy in that setting also.  ⭐️ Take away point: Consider endocrine therapy in ER low disease, especially in patients who did not achieve a pCR after neoadjuvant endocrine therapy.  Leave any questions you have below! Have you been treated with endocrine therapy for ER low disease?  #breastcancer #endocrinetherapy #tamoxifen #aromataseinhibitor #asco24 #chemotherapy
⭐️ This ASCO Study by Chong G et al. looked at 7,018 patients with stage 1-3 breast cancer classified as ER low who have received chemotherapy. 73% were PR negative and 65% were HER2 negative. Out of these patients, 42% did not receive adjuvant endocrine therapy. Omission of endocrine therapy was more common in patients that were PR negative and had Ki67>=20%, higher grade, clinically node negative and patients who received neoadjuvant chemotherapy. ❓What did they find? -At an average follow-up of 3 years, 586 people died. -94.3% of patients were alive at 2 years and 87.6% were alive at 4 years -Omission of endocrine therapy was associated with a worse overall survival regardless of PR status, HER2 status and Ki67 status. 🚨 The impact on survival by omitting endocrine therapy was only seen in those who did not have a pathologic complete response after neoadjuvant chemotherapy. In the patients who didn’t have a pCR, omission of endocrine therapy was associated with a 25% increase in the risk of death. 🚫 Limitations are that this was a retrospective study (meaning they looked back to find the data). We do not know the type of chemo, duration or adherence rates of endocrine therapy and breast cancer recurrence as all that data is not available. This study also did not look at ER 0%/PR positive disease so it’s hard to extrapolate to this population but we should keep this data in mind as we think about endocrine therapy in that setting also. ⭐️ Take away point: Consider endocrine therapy in ER low disease, especially in patients who did not achieve a pCR after neoadjuvant endocrine therapy. Leave any questions you have below! Have you been treated with endocrine therapy for ER low disease? #breastcancer #endocrinetherapy #tamoxifen #aromataseinhibitor #asco24 #chemotherapy

About